Wallis Stabilization System for Low Back Pain
A Prospective, Multi-center, Randomized, Active-Controlled Study of the Wallis System for the Treatment of Mild to Moderate Degenerative Disc Disease of the Lumbar Spine
1 other identifier
interventional
340
1 country
11
Brief Summary
The purpose of this study is to demonstrate that the Wallis System (interspinous process implant) is equivalent to total disc replacement (TDR) for the treatment of mild to moderate degenerative disc disease (DDD) of the lumbar spine at the L4-L5 level. This study will assess the safety and efficacy of the Wallis® System compared to commercially available lumbar TDR with respect to individual subject success rates at 24 months postoperative follow-up. Study participants will receive all study related test articles and surgical procedures at no charge. Please scroll down to the "Locations" section to find a doctor in your area that is participating in this study. If you are interested in participating in this study and do not see a doctor in your area, please contact Jose Naveira at jose.naveira@abbottspine.com
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 low-back-pain
Started Jan 2007
Longer than P75 for phase_3 low-back-pain
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 7, 2007
CompletedFirst Posted
Study publicly available on registry
June 11, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedOctober 4, 2011
October 1, 2011
6.8 years
June 7, 2007
October 3, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Non-inferior to commercially available lumber TDR after 24 months.
24 months
Study Arms (2)
1
EXPERIMENTALWallis Stabilization System
2
ACTIVE COMPARATORTotal Disc Replacement
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-60 (inclusive) and skeletally mature.
- Diagnosis of mild to moderate DDD at L4-L5 as confirmed by radiography.
- Minimum of six months of failed conservative treatment.
- Pre-operative visual analog (VAS) low back pain score ≥ 40, on a scale of 100mm, with low back pain greater than left or right leg pain.
- Preoperative baseline Oswestry Disability Index (ODI) score of ≥ 40 on a 100 point scale.
- Physically and mentally able to comply with the protocol, including ability to read and complete required forms, and willing and able to adhere to the follow-up requirements of the protocol.
- Voluntarily signs the patient informed consent form.
- Patient is a surgical candidate for an anterior approach to the lumbar spine (\< 3 abdominal surgeries).
You may not qualify if:
- The investigator believes that the L1-L2, L2-L3, L3-L4, or L5-S1 level is symptomatic based upon objective evidence, e.g., radiograph, MRI, or discography.
- Evidence of a prior fracture or trauma to the vertebral bodies at the affected level and/or the spinous processes at the L4-L5 or adjacent levels.
- Osteoporosis or osteopenia or metabolic bone disease as confirmed by DEXA scan (T score \< -1.0). Female subjects older than 45 years of age (or post-menopausal women, history of oophorectomy, or family history of osteoporosis) and male subjects older than 55 years will undergo a pre-operative, dual energy x-ray absorptiometry (DEXA) of the lumbar spine. The DEXA will be used to identify subjects with an indication of osteoporosis, osteopenia or metabolic bone disease. Subjects with a T-score of less than -1.0 will be excluded from the study.
- Congenital lumbar spinal stenosis.
- Bony lumbar stenosis.
- Extreme obesity, as defined by National Institutes of Health (NIH) Clinical Guidelines Body Mass Index (BMI \> 40kg/m2).
- A history of any surgical procedure intended to remove or alter the disc (e.g. discectomy, intradiscal electrothermal therapy (IDET) or enzymes), decompress (laminectomy) or fuse, either the index or adjacent levels.
- Prior participation in study of any investigational spinal implant or investigational spinal treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Spinelead
- Zimmer Biometcollaborator
Study Sites (11)
Spine Source
Beverly Hills, California, 90212, United States
Core Orthopaedic Medical Center
Encinitas, California, 92024, United States
Boulder Neurosurgical Associates
Boulder, Colorado, 80504, United States
Denver Spine
Greenwood Village, Colorado, 80111, United States
Illinois Bone & Joint Institute
Morton Grove, Illinois, 60053, United States
Fort Wayne Orthopaedics
Fort Wayne, Indiana, 46804, United States
Medical University of South Carolina
Charleston, North Carolina, 29425, United States
Triangle Orthopaedic Associates, P.A.
Durham, North Carolina, 27302, United States
Lehigh Valley Hospital
Allentown, Pennsylvania, 18103, United States
University of Utah-Dept. of Neurosurgery-Dept. of Orthopedic Surgery
Salt Lake City, Utah, 84132, United States
Aurora BayCare Medical Center
Green Bay, Wisconsin, 54311, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John J. Regan, MD
Spine Source
- PRINCIPAL INVESTIGATOR
Christopher Bergin, MD
Illinois Bone & Joint Institute
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2007
First Posted
June 11, 2007
Study Start
January 1, 2007
Primary Completion
November 1, 2013
Study Completion
November 1, 2014
Last Updated
October 4, 2011
Record last verified: 2011-10